<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_XJTLU-CHINA_Collaborations skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:XJTLU-CHINA/Collaborations</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="container"><DIV class="navbar-header"><BUTTON type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false" aria-controls="navbar"><SPAN class="sr-only">Toggle navigation</SPAN></BUTTON></DIV><DIV id="navbar" class="navbar-collapse collapse"><UL class="nav navbar-nav"><LI><A href="https://2017.igem.org/Team:XJTLU-CHINA">Home</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" role="button" aria-haspopup="true" aria-expanded="false">Project </A></LI><LI><A href="https://2017.igem.org/Team:XJTLU-CHINA/Description">Description</A></LI><LI><A href="https://2017.igem.org/Team:XJTLU-CHINA/Detection">Detection</A></LI><LI><A href="https://2017.igem.org/Team:XJTLU-CHINA/PeptideProduction">Peptide Production</A></LI><LI><A href="https://2017.igem.org/Team:XJTLU-CHINA/Lysis">Cell Lysis</A></LI><LI><A href="https://2017.igem.org/Team:XJTLU-CHINA/Model">Modeling</A></LI><LI><A href="https://2017.igem.org/Team:XJTLU-CHINA/Demonstrate">Demonstration</A></LI><LI><A href="https://2017.igem.org/Team:XJTLU-CHINA/Applied_Design">Application</A></LI></UL><LI class="dropdown"><A href="https://2017.igem.org/Team:XJTLU-CHINA/Parts" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Parts </A></LI><LI><A href="https://2017.igem.org/Team:XJTLU-CHINA/Basic_Part">Basic Parts</A></LI><LI><A href="https://2017.igem.org/Team:XJTLU-CHINA/Composite_Part">Composite Parts</A></LI><LI class="dropdown"><A href="https://2017.igem.org/Team:XJTLU-CHINA/Notebook" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Notebook </A></LI><LI><A href="https://2017.igem.org/Team:XJTLU-CHINA/Notebook">Lab Book</A></LI><LI><A href="https://2017.igem.org/Team:XJTLU-CHINA/Protocols">Protocols</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Human Practice</A></LI><LI><A href="https://2017.igem.org/Team:XJTLU-CHINA/HP/Gold_Integrated">HP_Gold</A></LI><LI><A href="https://2017.igem.org/Team:XJTLU-CHINA/HP/Silver">HP_Silver</A></LI><LI class="dropdown"><A href="https://2017.igem.org/Team:XJTLU-CHINA/Team" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Team </A></LI><LI><A href="https://2017.igem.org/Team:XJTLU-CHINA/Team">Members</A></LI><LI><A href="https://2017.igem.org/Team:XJTLU-CHINA/Attributions">Attributions</A></LI><LI><A href="https://2017.igem.org/Team:XJTLU-CHINA/Collaborations">Collaboration</A></LI><LI><A href="https://2017.igem.org/Team:XJTLU-CHINA/Safety">Safety</A></LI><LI><A href="https://2017.igem.org/Team:XJTLU-CHINA/InterLab">Interlab</A></LI></DIV></DIV><TITLE>Collaboration</TITLE><DIV class="title text-center"><H1 style="color:white; font-size:80px; padding-top:120px;">Collaboration</H1></DIV><DIV class="container"><DIV class="para"><H1>Collaboration with NAU-CHINA:</H1><P style="font-size:20px;">
                This year, we helped NAU-CHINA to construct two composite bioparts from the plasmid pFA6a-GFP(S65T)-kanMX6 into the plasmid
                pSB1C3:
            </P></DIV><DIV class="fig" align="center" id="f1"><FIGURE><FIGCAPTION><STRONG>Figure 1 plasmid pFA6a-GFP(S65T)-kanMX6</STRONG></FIGCAPTION></FIGURE></DIV><DIV class="fig" align="center" id="f2"><FIGURE><FIGCAPTION><STRONG>Figure 2 Two composite bioparts</STRONG></FIGCAPTION></FIGURE></DIV><DIV class="para"><H2><STRONG>--Design of the primers</STRONG></H2><P style="font-size:20px">          The strategy we chose was the conventional restriction digestion and cloning method. First we designed 8 primers to amplify
                the basic parts in the plasmid pFA6a-GFP(S65T)-kanMX6:
            </P></DIV><DIV class="spc"><P class="para" style="font-size:20px"><STRONG>Primer 1:</STRONG> 5’GCTCGAAGCTTCAGTAAAGGAGAAGAACTT 3’
            </P><P class="para" style="font-size:20px"><STRONG>Primer 2:</STRONG> 5’CTATCGGATCCCTATTTGTATAGTTCATCC 3’
            </P><P class="para" style="font-size:20px"><STRONG>Primer 3:</STRONG> 5’GATAAGAATTCGCGGCCGCTTCTAGAGATGACGACATGGAGGCCCAGAATAC 3’
            </P><P class="para" style="font-size:20px"><STRONG>Primer 4:</STRONG> 5’ACAGTCAAGCTTGGTTGTTTATGTTCGGATGTGATG 3
            </P><P class="para" style="font-size:20px"><STRONG>Primer 5:</STRONG> 5’ CCGTGCAGGATCCGCGAATTTCTTATGATTTATGATT 3’
            </P><P class="para" style="font-size:20px"><STRONG>Primer 6:</STRONG> 5’AGAATCTGCAGCGGCCGCTACTAGTACCGGTAGAGGTGTGG 3’
            </P><P class="para" style="font-size:20px"><STRONG>Primer 7:</STRONG> 5’CGCACTGGATCCACTGACAATAAAAAGATTCTTGT 3’
            </P><P class="para" style="font-size:20px"><STRONG>Primer 8:</STRONG> 5’ATAGCTGCAGCGGCCGCTACTAGTACAGTATAGCGACCAGCATT 3’
            </P><P class="para" style="font-size:20px">
                These parts were digested with restriction enzymes and ligated into the plasmid pSB1C3.
            </P></DIV><DIV class="para"><H2><STRONG>--The resultant plasmids</STRONG></H2></DIV><DIV class="fig" align="center"><FIGURE><FIGCAPTION><STRONG>Composite part 1</STRONG></FIGCAPTION></FIGURE><FIGURE><FIGCAPTION><STRONG>Composite part 2</STRONG></FIGCAPTION></FIGURE></DIV><DIV class="para"><P style="font-size:20px">And, we express our sincere thanks to NAU-CHINA who made lots of efforts to help us construct our mathematical
                models, and their works are shown below.</P></DIV><DIV class="para"><H2><STRONG>--The sensing device</STRONG></H2></DIV><DIV class="para"><P style="font-size:20px">
                By setting the parameters at random, the following graphs were generated.
            </P></DIV><DIV class="para"><H2><STRONG>--Peptide synthesis and cell lysis</STRONG></H2></DIV><DIV class="para"><P style="font-size:20px">
                By setting the parameters at random, the following graphs were generated.
            </P></DIV><DIV class="para"><H1>Collaboration with TMMU-China</H1><P style="font-size:20px">
                This year, TMMU-CHINA aimed to build a quorum sensing tool kit based on the Agr system from the Gram-positive bacteria--
                <I>Staphylococcus aureus.</I> However, they were not able to synthesize the genes agrC and agrA in plasmids,
                and therefore, the experiments were not able to conduct. Fortunately, we had the similar construction and
                provided them with our group I
                <I>Staphylococcus aureus’ </I>s agrC and agrA genes. The plasmid we sent them is shown below.
            </P></DIV><DIV class="para"><P style="font-size:20px">
                And, thanks to TMMU-CHINA for willing to help us to test the efficiency of antimicrobial peptides LL-37, GF-17, Grammistin-Pp1,
                and DRGN-1 on
                <I>Staphylococcus aureus </I>with our own protocols.
            </P></DIV><DIV class="para"><H1>Collaboration with ZJU-China</H1><P style="font-size:20px">
                When conducting the Interlab measurements, we accidentally kept LUDOX-S40 at -20 °C and made the silica irreversibly precipitated.
                Thanks to ZJU-CHINA for sending us a tube of LUDOX-S40, and thereafter, we carried on and successfully finished
                the experiments.
            </P></DIV><DIV class="para"><H1>Collaboration with Lanzhou (The iGEM team)</H1><P style="font-size:20px">
                In September, we received an invitation from Lanzhou iGEM team for a video interview on the dilemmas and issues our team
                had encountered and how we dealt with them. We conducted a video communication on 30th and exchanged ideas
                about the current situations of project development in our respective universities. Furthermore, the management
                of the iGEM team was also discussed in this conversation.
            </P><P style="font-size:20px">
                On balance, this conversation benefited both of our teams a lot. Through helping Lanzhou with their human practice investigation,
                we gained much experience on team operation and learned how to resolve the unforeseen issues.
            </P></DIV><DIV class="para"><H1>Collaboration with Greece（The iGEM team）</H1><P style="font-size:20px">
                In October, we helped Greece with a survey questionnaire about evaluating their project’s benefits and potential side effects.
            </P></DIV></DIV><DIV class="text-center" style="background:#cfe5d9;"><H1 style="font-weight:bolder;color:#006934; ">Collaborators and Supporters</H1><FOOTER><DIV class="text-center"><DIV class="container-fluid"><DIV class="row"><DIV class="col-md-4 loaction"><H4>Location</H4><P style="text-align:center;">Rm 363, Science Building
                                 Xi'an Jiaotong-Liverpool University
                                 111 Ren'ai Road, Suzhou, China
                                 215123
                            </P></DIV><DIV class="col-md-4 social"><H4>Social</H4></DIV><DIV class="col-md-4 contact"><H4>Get in touch</H4><P style="text-align:center;">igem@xjtlu.edu.cn</P></DIV></DIV></DIV></DIV><DIV class="text-center" style="background:#003b73;"><P style="text-align:center; color:white;">XJTLU-CHINA iGEM 2017</P></DIV></FOOTER></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>